Skip to main content


Page 1 of 61

  1. The specific pathophysiological pathways through which diabetes exacerbates myocardial ischemia/reperfusion (I/R) injury remain unclear; however, dysregulation of immune and inflammatory cells, potentially dri...

    Authors: De-Zhao Liu, Xiao-Zhi Luo, Chuang-Hong Lu, Yang-Yi Feng, De-Xin Chen, Zhi-Yu Zeng and Feng Huang
    Citation: Cardiovascular Diabetology 2024 23:202
  2. It’s unclear if excess visceral adipose tissue (VAT) mass in individuals with prediabetes can be countered by adherence to a Mediterranean lifestyle (MEDLIFE). We aimed to examine VAT mass, MEDLIFE adherence, ...

    Authors: Hao-Wen Chen, Kuan Liu, Bi-Fei Cao, Qi Zhong, Rui Zhou, Liang-Hua Li, Shi-Ao Wang, Yan-Fei Wei, Hua-Min Liu and Xian-Bo Wu
    Citation: Cardiovascular Diabetology 2024 23:201
  3. There is currently limited understanding of the relationship between copeptin, the midregional portion of proadrenomedullin (MRproADM) and the midregional fragment of the N-terminal of proatrial natriuretic pe...

    Authors: Lee Ti Davidson, Jan Engvall, Simona I. Chisalita, Carl Johan Östgren and Fredrik H. Nyström
    Citation: Cardiovascular Diabetology 2024 23:200
  4. Metformin and sodium-glucose-cotransporter-2 inhibitors (SGLT2i) are cornerstone therapies for managing hyperglycemia in diabetes. However, their detailed impacts on metabolic processes, particularly within th...

    Authors: Makoto Harada, Jonathan Adam, Marcela Covic, Jianhong Ge, Stefan Brandmaier, Caroline Muschet, Jialing Huang, Siyu Han, Martina Rommel, Markus Rotter, Margit Heier, Robert P. Mohney, Jan Krumsiek, Gabi Kastenmüller, Wolfgang Rathmann, Zhongmei Zou…
    Citation: Cardiovascular Diabetology 2024 23:199
  5. The TIM-HF2 study demonstrated that remote patient management (RPM) in a well-defined heart failure (HF) population reduced the percentage of days lost due to unplanned cardiovascular hospital admissions or al...

    Authors: Friedrich Koehler, Johanna Koehler, Peter Bramlage, Eik Vettorazzi, Karl Wegscheider, Susanne Lezius, Sebastian Spethmann, Roman Iakoubov, Anjaly Vijayan, Sebastian Winkler, Christoph Melzer, Katharina Schütt, Cécile Dessapt-Baradez, W.Dieter Paar, Kerstin Koehler and Dirk Müller-Wieland
    Citation: Cardiovascular Diabetology 2024 23:198
  6. Sodium glucose cotransporter 2 (SGLT2) inhibitors significantly improve cardiovascular outcomes in diabetic patients; however, the mechanism is unclear. We hypothesized that dapagliflozin improves cardiac outc...

    Authors: Dennis D. Wang, Anna V. Naumova, Daniel Isquith, Jamie Sapp, Kim A. Huynh, Isabella Tucker, Niranjan Balu, Anna Voronyuk, Baocheng Chu, Karen Ordovas, Charles Maynard, Rong Tian, Xue-Qiao Zhao and Francis Kim
    Citation: Cardiovascular Diabetology 2024 23:197
  7. Monocytes play a central role in the pathophysiology of cardiovascular complications in type 2 diabetes (T2D) patients through different mechanisms. We investigated diabetes-induced changes in lncRNA genes fro...

    Authors: Najeeb Halabi, Binitha Thomas, Omar Chidiac, Amal Robay, Julien AbiNahed, Amin Jayyousi, Jassim Al Suwaidi, Martina Bradic and Charbel Abi Khalil
    Citation: Cardiovascular Diabetology 2024 23:196
  8. Micro- and macrovascular diseases are common in patients with type 2 diabetes mellitus (T2D) and may be partly caused by nocturnal hypoxemia. The study aimed to characterize the composition of nocturnal hypoxe...

    Authors: Sarah Driendl, Stefan Stadler, Michael Arzt, Florian Zeman, Iris M. Heid and Mathias Baumert
    Citation: Cardiovascular Diabetology 2024 23:195
  9. Recent studies have suggested that insulin resistance (IR) contributes to the development of cardiovascular diseases (CVD), and the estimated glucose disposal rate (eGDR) is considered to be a reliable surroga...

    Authors: Zenglei Zhang, Lin Zhao, Yiting Lu, Yan Xiao and Xianliang Zhou
    Citation: Cardiovascular Diabetology 2024 23:194
  10. Cardiovascular disease (CVD) is closely associated with the triglyceride glucose (TyG) index and its related indicators, particularly its combination with obesity indices. However, there is limited research on...

    Authors: Xiaoqing Zhu, Weihao Xu, Tingting Song, Xinyan Wang, Qingsong Wang, Jun Li, Xixi Liu, Benchuan Hao, Tao Chen and Jun Guo
    Citation: Cardiovascular Diabetology 2024 23:192
  11. The purpose of this study was to explore the prognostic significance of the lesion-specific pericoronary fat attenuation index (FAI) in forecasting major adverse cardiovascular events (MACE) among patients wit...

    Authors: Meiju Liu, Yanhua Zhen, Jin Shang, Yuxue Dang, Qian Zhang, Weishi Ni, Yujuan Qiao and Yang Hou
    Citation: Cardiovascular Diabetology 2024 23:191
  12. Coronary three-vessel disease (CTVD) accounts for one-third of the overall incidence of coronary artery disease, with heightened mortality rates compared to single-vessel lesions, including common trunk lesion...

    Authors: Zheng Qiao, Xiaohui Bian, Chenxi Song, Rui Zhang, Sheng Yuan, Zhangyu Lin, Chenggang Zhu, Qianqian Liu, Wenjun Ma and Kefei Dou
    Citation: Cardiovascular Diabetology 2024 23:190
  13. Authors: Aftab Ahmad and Hani Sabbour
    Citation: Cardiovascular Diabetology 2024 23:189

    The original article was published in Cardiovascular Diabetology 2024 23:99

  14. Insulin resistance (IR) plays a vital role in the pathogenesis of the metabolic dysfunction-associated steatotic liver disease (MASLD). However, it remains unclear whether triglyceride–glucose (TyG) related pa...

    Authors: Yu Min, Xiaoyuan Wei, Zhigong Wei, Ge Song, Xin Zhao and Yi Lei
    Citation: Cardiovascular Diabetology 2024 23:188
  15. Ischemia and no obstructive coronary artery disease (INOCA) is increasingly recognized and associated with poor outcomes. The triglyceride-glucose (TyG) index is a reliable alternative measure of insulin resis...

    Authors: Wen Zhang, Lu Liu, Guoqing Yin, Abdul-Quddus Mohammed, Lanqing Xiang, Xian Lv, Tingting Shi, Jassur Galip, Chunyue Wang, Ayman A. Mohammed, Redhwan M. Mareai, Fei Yu, Fuad A. Abdu and Wenliang Che
    Citation: Cardiovascular Diabetology 2024 23:187
  16. Vascular calcification (VC) is an independent risk factor for cardiovascular diseases. Recently, ferroptosis has been recognised as a novel therapeutic target for cardiovascular diseases. Although an associati...

    Authors: Yierpani Aierken, Huqiang He, Runwen Li, Zipeng Lin, Tongjie Xu, Li Zhang, Ya Wu and Yong Liu
    Citation: Cardiovascular Diabetology 2024 23:186
  17. Triglyceride and glucose (TyG) index, a surrogate marker of insulin resistance, has been validated as a predictor of cardiovascular disease. However, effects of TyG-related indices combined with obesity marker...

    Authors: Cancan Cui, Yitian Qi, Jiayin Song, Xinyun Shang, Tianjiao Han, Ning Han, Siqi Yue, Yining Zha, Zhonghang Xu, Jiannan Li and Lin Liu
    Citation: Cardiovascular Diabetology 2024 23:185
  18. Use of sodium-glucose-cotransporter-2 (SGLT2) inhibitors often causes an initial decline in glomerular filtration rate (GFR). This study addresses the question whether the initial decline of renal function wit...

    Authors: Merve Günes-Altan, Agnes Bosch, Kristina Striepe, Peter Bramlage, Mario Schiffer, Roland E. Schmieder and Dennis Kannenkeril
    Citation: Cardiovascular Diabetology 2024 23:184
  19. People with type 2 diabetes (T2D) are at elevated risk of cardiovascular disease (CVD) including stroke, yet existing real-world evidence (RWE) on the clinical and economic burden of stroke in this population ...

    Authors: Kamel Mohammedi, Laurent Fauchier, Nadia Quignot, Artak Khachatryan, Tamar Banon, Raissa Kapnang, Kazue Kikuchi, Hongye Ren, Christine Massien, Lucile Vigié, Sara Larsen and Igor Sibon
    Citation: Cardiovascular Diabetology 2024 23:183
  20. Left ventricular global longitudinal strain (GLS) holds greater diagnostic and prognostic value than left ventricular ejection fraction (LVEF) in the heart failure (HF) patients. The triglyceride-glucose (TyG)...

    Authors: Shuai Zhang, Yan Liu, Fangfang Liu, Qing Ye, Dachuan Guo, Panpan Xu, Tianhao Wei, Cheng Zhang and Huixia Lu
    Citation: Cardiovascular Diabetology 2024 23:182
  21. Atherosclerosis is the main cause of stroke and coronary heart disease (CHD), both

    Authors: Mohamed A. Elhadad, Mónica del C. Gómez-Alonso, Chien-Wei Chen, Sonja Neumeyer, Thomas Delerue, Wolfgang Rathmann, Michael Näbauer, Christa Meisinger, Stefan Kääb, Jochen Seissler, Johannes Graumann, Wolfgang Koenig, Karsten Suhre, Christian Gieger, Uwe Völker, Annette Peters…
    Citation: Cardiovascular Diabetology 2024 23:181
  22. Authors: Gaetano Santulli, Valeria Visco, Michele Ciccarelli, Mario Nicola Vittorio Ferrante, Piero De Masi, Antonella Pansini, Nicola Virtuoso, Armando Pirone, Germano Guerra, Veronica Verri, Gaetano Macina, Alessandro Taurino, Klara Komici and Pasquale Mone
    Citation: Cardiovascular Diabetology 2024 23:180

    The original article was published in Cardiovascular Diabetology 2024 23:125

  23. Stress hyperglycemia, which is associated with poor prognosis in patients with acute myocardial infarction (AMI), can be determined using the stress hyperglycemia ratio (SHR). Impaired left ventricular functio...

    Authors: Kairui Bo, Weibo Li, Hongkai Zhang, Yan Wang, Zhen Zhou, Yifeng Gao, Zhonghua Sun, Jianxiu Lian, Hui Wang and Lei Xu
    Citation: Cardiovascular Diabetology 2024 23:179
  24. Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in patients with Type 1 Diabetes (T1D). Early markers of CVD include increased carotid intima-media thickness (CIMT) and pulse ...

    Authors: Michael J. De Biasio, Michelle Furman, Antoine Clarke, Wei Hui, Yesmino Elia, Jerome Baranger, Olivier Villemain, Luc Mertens and Farid H. Mahmud
    Citation: Cardiovascular Diabetology 2024 23:178
  25. Numerous meta-analyses have explored the association between the triglyceride-glucose (TyG) index and diverse health outcomes, yet the comprehensive assessment of the scope, validity, and quality of this evide...

    Authors: Jia-Li Yin, Jing Yang, Xin-Jian Song, Xue Qin, Yu-Jiao Chang, Xing Chen, Fang-Hua Liu, Yi-Zi Li, He-Li Xu, Yi-Fan Wei, Fan Cao, Xue-Li Bai, Lang Wu, Tao Tao, Jian Du, Ting-Ting Gong…
    Citation: Cardiovascular Diabetology 2024 23:177
  26. There is conflicting evidence whether prediabetes is associated with adverse clinical outcomes in patients with chronic coronary syndrome. We aimed to assess the effect of prediabetes in patients with chronic ...

    Authors: Anselm Jorda, Christian Hengstenberg, Irene M. Lang, Alexandra Kautzky-Willer, Jürgen Harreiter, Markus Zeitlinger, Bernd Jilma and Georg Gelbenegger
    Citation: Cardiovascular Diabetology 2024 23:176
  27. Insulin resistance (IR) is the cornerstone of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD), pathophysiologically being the key link between MASLD, metabolic disorders, and cardiovascular (C...

    Authors: Alessandra Colantoni, Tommaso Bucci, Nicholas Cocomello, Francesco Angelico, Evaristo Ettorre, Daniele Pastori, Gregory Y.H. Lip, Maria Del Ben and Francesco Baratta
    Citation: Cardiovascular Diabetology 2024 23:175
  28. Growth differentiation factor 15 (GDF15) is a mitokine, the role of which, total or H-specific, in modulating energy metabolism and homeostasis in obesity-related diseases, such as metabolic dysfunction associ...

    Authors: Chrysoula Boutari, Konstantinos Stefanakis, Stamatia Simati, Valentina Guatibonza-García, Laura Valenzuela-Vallejo, Ioanna A. Anastasiou, Margery A. Connelly, Alexander Kokkinos and Christos S. Mantzoros
    Citation: Cardiovascular Diabetology 2024 23:174
  29. Insulin resistance (IR) significantly contributes to cardiovascular disease (CVD) development. Triglyceride glucose (TyG) index and triglyceride glucose-body mass index (TyG-BMI) are recognised as convenient p...

    Authors: Shuijing Zhang, Wenbing Liu, Bin Xu, Shuguang Wang, Zhongyan Du and Wenke Cheng
    Citation: Cardiovascular Diabetology 2024 23:173
  30. Insulin resistance (IR) is linked to both the complexity of coronary artery lesions and the prognosis of acute coronary syndrome (ACS). However, the precise extent of this correlation and its impact on adverse...

    Authors: Qiang Chen, Shiqiang Xiong, Tao Ye, Yanxiang Gao, Jian Wang, Xingliang Li, Yike Li, Caiyan Cui, Hanxiong Liu, Zhen Zhang, Lin Cai and Jingang Zheng
    Citation: Cardiovascular Diabetology 2024 23:172
  31. Although studies have demonstrated the value of the triglyceride–glucose (TyG) index for cardiovascular disease (CVD) and cardiovascular mortality, however, few studies have shown that the TyG index is associa...

    Authors: Chang Liu, Dan Liang, Kun Xiao and Lixin Xie
    Citation: Cardiovascular Diabetology 2024 23:171
  32. Although the TyG index is a reliable predictor of insulin resistance (IR) and cardiovascular disease, its effectiveness in predicting major adverse cardiac events in hospitalized acute coronary syndrome (ACS) ...

    Authors: Wenjie Wang, Jiaxin Yang, Kexin Wang, Jialong Niu, Yixuan Liu and Hailong Ge
    Citation: Cardiovascular Diabetology 2024 23:170
  33. Diabetic heart disease (DHD) is a serious complication in patients with diabetes. Despite numerous studies on the pathogenic mechanisms and therapeutic targets of DHD, effective means of prevention and treatme...

    Authors: Chaoyue Zhang, Yunke Shi, Changzhi Liu, Shivon Mirza Sudesh, Zhao Hu, Pengyang Li, Qi Liu, Yiming Ma, Ao Shi and Hongyan Cai
    Citation: Cardiovascular Diabetology 2024 23:169
  34. The relationship between the triglyceride–glucose (TyG) index and the risk of cardiovascular disease (CVD) in the U.S. population under 65 years of age with diabetes or prediabetes is unknown. The purpose of t...

    Authors: Chang Liu and Dan Liang
    Citation: Cardiovascular Diabetology 2024 23:168
  35. Metabolic dysfunction-associated steatotic liver disease (MASLD) is the proposed name change for non-alcoholic fatty liver disease (NAFLD). This study aimed to investigate the association of cardiovascular dis...

    Authors: Takahiro Nishihara, Toru Miyoshi, Mitsutaka Nakashima, Takashi Miki, Hironobu Toda, Masatoki Yoshida, Keishi Ichikawa, Kazuhiro Osawa and Shinsuke Yuasa
    Citation: Cardiovascular Diabetology 2024 23:167
  36. Studies have shown that RASGRP1 was potently associated with the onset of type 2 diabetes mellitus (T2DM), and RASGRP1 rs7403531 was significantly correlated with islet function in T2DM patients. However, the eff...

    Authors: Jiecan Zhou, Bo Xu, Fazhong He, Yan Shu, Xiaoping Chen, Zhaoqian Liu, Bao Sun and Wei Zhang
    Citation: Cardiovascular Diabetology 2024 23:166
  37. To investigate the contributions of low-grade inflammation measured by C-reactive protein (CRP), hyperglycaemia, and type 2 diabetes to risk of ischemic heart disease (IHD) and cardiovascular disease (CVD) dea...

    Authors: Monica G Rolver, Frida Emanuelsson, Børge G Nordestgaard and Marianne Benn
    Citation: Cardiovascular Diabetology 2024 23:165
  38. Dynamin-related protein 1 (Drp1) is a crucial regulator of mitochondrial dynamics, the overactivation of which can

    Authors: Yuqiong Chen, Su Li, Bo Guan, Xiaopei Yan, Chao Huang, Yingqiang Du, Fan Yang, Nannan Zhang, Yafei Li, Jian Lu, Jiankang Wang, Jun Zhang, Zhangwei Chen, Chao Chen and Xiangqing Kong
    Citation: Cardiovascular Diabetology 2024 23:164
  39. Sepsis is a severe form of systemic inflammatory response syndrome that is caused by infection. Sepsis is characterized by a marked state of stress, which manifests as nonspecific physiological and metabolic c...

    Authors: Fengjuan Yan, Xiehui Chen, Xiaoqing Quan, Lili Wang, Xinyi Wei and Jialiang Zhu
    Citation: Cardiovascular Diabetology 2024 23:163
  40. The triglyceride glucose-body mass index (TyG-BMI) is recognized as a reliable surrogate for evaluating insulin resistance and an effective predictor of cardiovascular disease. However, the link between TyG-BM...

    Authors: Lyu Lyu, Xinhong Wang, Juan Xu, Zhenzhen Liu, Yanru He, Wenjing Zhu, Lin Lin, Benchuan Hao and Hongbin Liu
    Citation: Cardiovascular Diabetology 2024 23:162
  41. The association between the triglyceride–glucose (TyG) index and subclinical left ventricular (LV) systolic dysfunction in obese patients remains unclear. This study aimed to investigate the relationship betwe...

    Authors: Guang-an Li, Jun Huang, Jing Wang and Li Fan
    Citation: Cardiovascular Diabetology 2024 23:161
  42. In observational and experimental studies, diabetes has been reported as a protective factor for aortic dissection. 3-Hydroxybutyrate, a key constituent of ketone bodies, has been found to favor improvements i...

    Authors: Shi Qiu, Zhen Liu, Wei-Dong Jiang, Jin-Hui Sun, Zeng-Qiang Liu, Xiao-Di Sun, Chun-Ting Wang and Wen Liu
    Citation: Cardiovascular Diabetology 2024 23:159
  43. The association between iron biomarkers and cardiovascular disease risk factors (CVD-RFs) remains unclear. We aimed to (1) evaluate the cross-sectional and longitudinal associations between iron biomarkers (se...

    Authors: Noushin Sadat Ahanchi, Amira Salomé Fischer, Hugo G. Quezada-Pinedo, Farnaz khatami, Michele F. Eisenga, Taulant Muka and Pedro-Marques Vidal
    Citation: Cardiovascular Diabetology 2024 23:158
  44. Sodium-glucose cotransporter 2 (SGLT2) and SGLT1 inhibitors may have additional beneficial metabolic effects on circulating metabolites beyond glucose regulation, which could contribute to a reduction in the b...

    Authors: Yanchen Lv, Xin Cheng and Qiang Dong
    Citation: Cardiovascular Diabetology 2024 23:157
  45. Both the triglyceride-glucose (TyG) index, as a surrogate marker of insulin resistance, and systemic inflammation are predictors of cardiovascular diseases; however, little is known about the coexposures and r...

    Authors: Cancan Cui, Lin Liu, Yitian Qi, Ning Han, Haikun Xu, Zhijia Wang, Xinyun Shang, Tianjiao Han, Yining Zha, Xin Wei and Zhiyuan Wu
    Citation: Cardiovascular Diabetology 2024 23:156
  46. Given the increasing attention to glycemic variability (GV) and its potential implications for cardiovascular outcomes. This study aimed to explore the impact of acute GV on short-term outcomes in Chinese pati...

    Authors: Juan Wang, Lu-lu Wang, Yan-min Yang, Hui-qiong Tan and Jun Zhu
    Citation: Cardiovascular Diabetology 2024 23:155
  47. Type 2 Diabetes Mellitus (T2DM) presents a significant healthcare challenge, with considerable economic ramifications. While blood glucose management and long-term metabolic target setting for home care and ou...

    Authors: Salvatore Greco, Alessandro Salatiello, Francesco De Motoli, Antonio Giovine, Martina Veronese, Maria Grazia Cupido, Emma Pedarzani, Giorgia Valpiani and Angelina Passaro
    Citation: Cardiovascular Diabetology 2024 23:153
  48. Vasculopathy is the most common complication of diabetes. Endothelial cells located in the innermost layer of blood vessels are constantly affected by blood flow or vascular components; thus, their mechanosens...

    Authors: Xiaoyu Zhang, Shaoqiu Leng, Xinyue Liu, Xiang Hu, Yan Liu, Xin Li, Qi Feng, Wei Guo, Nailin Li, Zi Sheng, Shuwen Wang and Jun Peng
    Citation: Cardiovascular Diabetology 2024 23:150

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    3,115 Altmetric mentions